Basit öğe kaydını göster

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

dc.contributor.authorSAYDAM, GÜRAY
dc.contributor.authorYildiz, Birol
dc.contributor.authorUZAY, Ant
dc.contributor.authorYigenoglu, Tugce Nur
dc.contributor.authorTOPTAŞ, TAYFUR
dc.contributor.authorDogu, Mehmet Hilmi
dc.contributor.authorSALİM, OZAN
dc.contributor.authorYAVAŞOĞLU, İRFAN
dc.contributor.authorAyli, Meltem
dc.contributor.authorOzet, Gulsum
dc.contributor.authorAlbayrak, Murat
dc.contributor.authorAtesoglu, Elif Birtas
dc.contributor.authorTOPRAK, SELAMİ KOÇAK
dc.contributor.authorYILDIRIM, Rahşan
dc.contributor.authorMEHTAP, ÖZGÜR
dc.contributor.authorBesisik, Sevgi Kalayoglu
dc.contributor.authorNalcaci, Meliha
dc.contributor.authorAltuntas, Fevzi
dc.contributor.authorFerhanoglu, Burhan
dc.contributor.authorELVERDİ, Tuğrul
dc.contributor.authorKAYNAR, LEYLAGÜL
dc.contributor.authorAyyildiz, Orhan
dc.contributor.authorHindilerden, Ipek Yonal
dc.contributor.authorGoksoy, Hasan Sami
dc.contributor.authorGuner, Sebnem Izmir
dc.contributor.authorGunes, Ahmet Kursad
dc.contributor.authorSÖNMEZ, MEHMET
dc.contributor.authorYuksel, Meltem Kurt
dc.contributor.authorBozdag, Sinem Civriz
dc.contributor.authorÖZKURT, ZÜBEYDE NUR
dc.contributor.authorOzbalak, Murat
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorPEHLİVAN, MUSTAFA
dc.date.accessioned2021-12-10T12:58:07Z
dc.date.available2021-12-10T12:58:07Z
dc.identifier.citationOzbalak M., Akay O. M. , PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N. , ELVERDİ T., KAYNAR L., Ayyildiz O., Hindilerden I. Y. , et al., "Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study", CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021
dc.identifier.issn2152-2650
dc.identifier.othervv_1032021
dc.identifier.otherav_e5a6129e-18e7-4d48-aaf0-2f5c1ba61d94
dc.identifier.urihttp://hdl.handle.net/20.500.12627/175121
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectHEMATOLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHematology
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.titleBrentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
dc.typeMakale
dc.relation.journalCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
dc.contributor.departmentİstanbul Teknik Üniversitesi , ,
dc.identifier.volume21
dc.contributor.firstauthorID2735880


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster